BioNexus KC
US biotechs gave China control over your medicine; here’s how KC’s $38M+ BioHub initiative could win it back
“Biologic medicines are the drugs of the future: the insulin that manages a child’s diabetes, the immunotherapy that shrinks a tumor, the vaccine that stops a pandemic in its tracks,” said Melissa Roberts Chapman. The problem: China already has a 30-year head start controlling access to those critical medicines.
KC BioHub earns $38M+ to position KC as ‘next great biotech ecosystem’ amid global biomanufacturing race
Kansas City is poised to unlock $150 million in federal investment thanks to a winning bid led by the region’s Tech Hub to accelerate biomanufacturing innovation, workforce development, and industry growth across the region.
Maria Meyers is passing the blueprint to KC’s ecosystem; it doesn’t come with a magic wand
“In an environment that is constantly changing and evolving, learning from each other is just part of the fabric of crafting something bigger and better,” said Maria Meyers.
BioNexus KC catalyzes 25 years of work at the crossroads of collaboration, health innovation
A quarter-century commitment to regional investment and collaboration is paying off, said Dennis Ridenour, reflecting on a timeline of impact for BioNexus KC — accelerating innovation and strengthening health outcomes in Kansas City and beyond. “This milestone is not about a single achievement; it’s about decades of collective, focused effort that have allowed our ecosystem…
KC BioHub leaders refining plan after $75M Tech Hubs proposal fails initial test
A massive regional initiative to secure federal funds for Kansas City’s burgeoning Tech Hub failed to win approval, BioNexus KC officials announced Tuesday, with advocates lauding organizers’ efforts and pledging to continue their push. The KC BioHub was seeking funding Phase II funding from the Economic Development Administration (EDA) Tech Hubs competition — a process…
